Around delivery, a mixture of nitrous oxide and oxygen (Entonox®) was used for pain relief during labor. The baby was born cyanotic, floppy with no respiratory effort and no chest wall movement. After two cycles of assisted breaths, the patient remained bradycardic with heart rate <20/min and therefore, chest compressions were initiated. The patient was intubated with size -3.5 tube which resulted in an improvement in his oxygenation and circulatory response.
INTRODUCTION
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease characterized by progressive symmetrical muscle weakness resulting from the degeneration and loss of anterior horn cells in the spinal cord and brain stem nuclei. It is the most common genetic cause of infant mortality, affecting approximately 1 in 10,000 live births. [1] The disease is conventionally classified into four phenotypes [ Table 1 ]. [2] In 1999, MacLeod et al. have described five cases of very severe SMA Type 1, all of whom presented with reduced fetal movements in utero, severe weakness at birth, and short survival time. [3] 
CASE REPORT
This male newborn was the second child of unrelated parents. He was born by spontaneous vaginal delivery at 38 + 0 weeks of gestation weighing 2620 g. Antenatally, the mother, noticed reduced fetal movements in the last 2 weeks of gestation, and there was polyhydramnios on antenatal scans. She is a nonsmoker and denies any alcohol or drugs consumption.
In genetic studies, myotonic dystrophy Type 1 was negative but the baby was homozygously deleted for exon 7 and exon 8 of survival motor neuron gene 1 (SMN1).
The diagnosis was fully explained to parents and on day 12 of life, the baby was discharged to the local hospice for compassionate extubation after which he passed away.
DISCUSSION
SMA is caused by homozygous deletions or mutations in the SMN1 gene on chromosome 5 q13. [4] SMN1 exon 7 is homozygously absent in approximately 94% of patients with clinically typical SMA. [5] There is a marked correlation between SMN-encoded protein levels and disease severity in SMA. [6] In all SMA Type 0 cases reported by MacLeod and her team, centromeric SMN gene was present but in reduced copy number compared with a control group of children with the less severe Type 1 SMA. [3] Although in this case, SMA has been confirmed, polyhydramnios, to some extent, might have contributed to the clinical features and presentation. Cessation of fetal movements associated with polyhydramnios has been reported in the medical literature. [7] A review showed that, in polyhydramnios, there is a 2-5-fold increase in the risk of perinatal mortality. [8] Patients with SMA and their families or carers should be routinely offered genetic counseling. Being an autosomal recessive disease indicates that there is a 25% chance to have an affected child if both parents were found to be carriers. In an American study, Caucasians have the highest carrier's frequency and detection rate whereas African Americans had the lowest. [9] Financial support and sponsorship Nil.
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